TNF and inflammatory bowel disease: In another retrospective study conducted on the Danish population by Villumsen et al. [59], a lower risk in the composite outcome of the need for oral corticosteroids, TNF-α inhibitors, IBD-related hospitalisation, and IBD-related surgery was found [adjusted incidence rate ratio (IRR): 0.52, 95%CI 0.42–0.65].